BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Zelos Therapeutics 



Waltham  Massachusetts    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Zelos Therapeutics Initiates Dosing in a Phase 1 Clinical Study of Nasal Spray Teriparatide 1/28/2010 8:30:18 AM    More...
Zelos Therapeutics Initiates Clinical Study of First US Injectable Equivalent to Forteo(R) (teriparatide) 10/7/2009 7:59:41 AM    More...
Zelos Therapeutics to Present at Two Investor Conferences 10/23/2008 12:17:18 PM    More...
Zelos Therapeutics Reaches Agreement with the FDA and EMEA for a Registration Study of ZT-031 for the Treatment of Osteoporosis 7/24/2008 7:19:26 AM    More...
Zelos Therapeutics Appoints Alan S. Roemer as Chief Financial Officer 6/17/2008 8:55:22 AM    More...
Zelos Therapeutics and Aegis Therapeutics, LLC Announce Collaboration for Intranasal Delivery of Zelos' ZT-031 4/16/2008 6:54:46 AM    More...
Zelos Therapeutics Appoints David S. Krause, MD, FACP, as Chief Medical Officer 3/20/2008 8:49:53 AM    More...
Zelos Therapeutics Presents Positive Data at ASBMR on Subcutaneous and Inhaled Delivery of Cyclic PTH (1-31) (Ostabolin-C(TM)) 9/19/2007 10:47:40 AM    More...
Zelos Therapeutics' Ostabolin-C(TM) Increases Bone Mineral Density In Phase 2 Osteoporosis Trial 2/8/2007 11:52:40 AM    More...
The Day In Review: Big M&A Activity In Biotech 9/21/2006 6:43:54 PM    More...
123

//-->